|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5750119A
(en)
*
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5961979A
(en)
*
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US6455493B1
(en)
|
1996-09-20 |
2002-09-24 |
University Of New Mexico |
Methods for using heat shock proteins
|
|
EP0950061A4
(en)
|
1996-09-20 |
2000-04-12 |
Univ New Mexico |
Heat shock protein complexes
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
HUP0003601A3
(en)
*
|
1997-08-05 |
2003-03-28 |
Stressgen Biotechnologies Corp |
Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
US6007821A
(en)
*
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US6331388B1
(en)
*
|
1997-10-17 |
2001-12-18 |
Wisconsin Alumni Research Foundation |
Immune response enhancer
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
ES2355483T3
(es)
*
|
1998-02-20 |
2011-03-28 |
University Of Miami |
Complejo de proteina de choque térmico modificada-péptido antigénico.
|
|
WO1999048914A1
(en)
*
|
1998-03-26 |
1999-09-30 |
The University Of New Mexico |
Methods for using heat shock proteins
|
|
CA2323833A1
(en)
*
|
1998-03-31 |
1999-10-07 |
Genzyme Corporation |
Compositions and methods for the identification of lung tumor cells
|
|
US6475490B1
(en)
*
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
WO2001040292A1
(en)
*
|
1998-11-27 |
2001-06-07 |
Novopharm Biotech Inc. |
Antigen-binding fragments specific for tumor associated antigens
|
|
US20040166527A1
(en)
*
|
1999-03-30 |
2004-08-26 |
Beaudry Gary A. |
Compositions and methods for the identification of lung tumor cells
|
|
US6495360B1
(en)
|
1999-05-28 |
2002-12-17 |
Photogen, Inc. |
Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
|
|
AU5926700A
(en)
*
|
1999-07-08 |
2001-01-30 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
AUPQ233799A0
(en)
*
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
US7378096B2
(en)
*
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
WO2001023421A2
(en)
|
1999-09-30 |
2001-04-05 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
*
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
US7235649B2
(en)
*
|
2000-03-24 |
2007-06-26 |
Duke University |
Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
|
|
WO2001079259A1
(en)
*
|
2000-04-17 |
2001-10-25 |
Rothman James E |
Javelinization of protein antigens to heat shock proteins
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
US7179462B2
(en)
|
2000-06-02 |
2007-02-20 |
University Of Connecticut Health Center |
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
US7186515B1
(en)
|
2000-06-02 |
2007-03-06 |
University Of Connecticut Health Center |
Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
KR100919266B1
(ko)
|
2000-06-26 |
2009-09-30 |
엔벤타 바이오파마슈티컬스 코포레이션 |
인간 파필로마 바이러스 치료법
|
|
DE10033245A1
(de)
*
|
2000-07-10 |
2002-01-24 |
Singh Jasuja Harpreet |
Verwendungen des Hitzeschockproteins gp96
|
|
EP1363938B1
(en)
*
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
AU2001292674A1
(en)
*
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
*
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
WO2002057795A2
(en)
*
|
2001-01-19 |
2002-07-25 |
Cambridge Scientific, Inc. |
Methods of diagnosis and treatment of osteoporosis
|
|
US6921534B2
(en)
*
|
2001-02-05 |
2005-07-26 |
Stressgen Biotechnologies Corporation |
Hepatitis B virus treatment
|
|
US6855925B2
(en)
*
|
2001-02-14 |
2005-02-15 |
Picoliter Inc. |
Methods, devices, and systems using acoustic ejection for depositing fluid droplets on a sample surface for analysis
|
|
US20040043419A1
(en)
*
|
2001-04-17 |
2004-03-04 |
Rothman James E. |
Javelinization of protein antigens to heat shock proteins
|
|
HK1079705A1
(zh)
*
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
US20030211971A1
(en)
*
|
2001-09-17 |
2003-11-13 |
Srivastava Pramod K. |
Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
|
|
JP2005512519A
(ja)
*
|
2001-10-01 |
2005-05-12 |
デューク・ユニバーシティ |
単離grp94リガンド結合ドメインポリペプチドおよびそれをコードする核酸、その結晶、およびそれを用いるスクリーニング方法
|
|
US6850804B2
(en)
*
|
2002-01-18 |
2005-02-01 |
Calfacior Corporation |
System method and apparatus for localized heating of tissue
|
|
US6993394B2
(en)
|
2002-01-18 |
2006-01-31 |
Calfacion Corporation |
System method and apparatus for localized heating of tissue
|
|
US7048756B2
(en)
*
|
2002-01-18 |
2006-05-23 |
Apasara Medical Corporation |
System, method and apparatus for evaluating tissue temperature
|
|
EP2157101B1
(en)
*
|
2002-01-31 |
2014-09-24 |
Andromeda Bio Tech Ltd. |
HSP peptides and analogs for modulation of immune responses via antigen presenting cells
|
|
US20050221421A1
(en)
*
|
2002-02-08 |
2005-10-06 |
Tran Jean-Luc V |
Method of producing and using heat shock proteins
|
|
AU2003216288B2
(en)
*
|
2002-02-13 |
2009-09-24 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
WO2003074003A2
(en)
*
|
2002-03-01 |
2003-09-12 |
Applied Immune Technologies |
Immunogens for treatment of neoplastic and infectious disease
|
|
AU2003231098A1
(en)
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
CN1665533A
(zh)
*
|
2002-05-02 |
2005-09-07 |
康涅狄格大学健康中心 |
热激蛋白用于增强抗体疗法功效的用途
|
|
WO2004033657A2
(en)
*
|
2002-10-07 |
2004-04-22 |
Antigenics, Inc. |
Heat shock protein binding fragments of cd91, and uses thereof
|
|
GB0223696D0
(en)
*
|
2002-10-14 |
2002-11-20 |
Ml Lab Plc |
Improved immunotherapy
|
|
JP2006514088A
(ja)
*
|
2003-02-20 |
2006-04-27 |
ユニバーシティー オブ コネティカット ヘルス センター |
癌および感染症の治療における熱ショックタンパク質またはα−2−マクログロブリンを含む組成物の使用方法
|
|
EP1644048B1
(en)
*
|
2003-05-05 |
2015-04-29 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
US8541002B2
(en)
*
|
2003-09-12 |
2013-09-24 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
CN101052709B
(zh)
*
|
2004-10-25 |
2012-06-27 |
贝勒研究院 |
装载热激黑素瘤细胞体的树突细胞
|
|
WO2006073970A2
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
US20070098735A1
(en)
*
|
2005-10-29 |
2007-05-03 |
Chandawarkar Rajiv Y |
Methods for the Elimination of Pathogens and Other Particulate Agents
|
|
US20100330105A1
(en)
*
|
2006-08-22 |
2010-12-30 |
John Hopkins University |
Anticancer Combination Therapies
|
|
US20080089875A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Zheng Cui |
Methods and compositions for the treatment of cancer
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
WO2009114085A2
(en)
|
2008-03-03 |
2009-09-17 |
The University Of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
JP5616336B2
(ja)
|
2008-06-26 |
2014-10-29 |
オルファザイム エーピーエスOrphazyme Aps |
酵素活性の調節因子としてのHsp70の使用
|
|
EP2358383A4
(en)
*
|
2008-11-21 |
2011-11-23 |
Univ Miami |
HIV / SIV VACCINES FOR THE MANUFACTURE OF SLEEPAGE AND SYSTEM IMMUNITY
|
|
MX2011005915A
(es)
|
2008-12-03 |
2011-08-17 |
Proyecto Biomedicina Cima Sl |
Uso de modulinas solubles en fenol para el desarrollo de vacunas.
|
|
US9662375B2
(en)
|
2010-11-30 |
2017-05-30 |
Orphazyme Aps |
Methods for increasing intracellular activity of Hsp70
|
|
WO2012123269A1
(en)
|
2011-03-11 |
2012-09-20 |
Proyecto De Biomedicina Cima, S.L. |
Immunogenic compositions and methods for their use
|
|
EP2505640A1
(en)
|
2011-03-29 |
2012-10-03 |
Neo Virnatech, S.L. |
Vaccine compositions for birnavirus-borne diseases
|
|
US10709700B2
(en)
|
2014-09-15 |
2020-07-14 |
Orphazyme A/S |
Arimoclomol formulation
|
|
US10046047B2
(en)
|
2015-02-06 |
2018-08-14 |
Heat Biologics, Inc. |
Vector co-expressing vaccine and costimulatory molecules
|
|
EP3294324A1
(en)
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
WO2017178029A1
(en)
|
2016-04-13 |
2017-10-19 |
Orphazyme Aps |
Heat shock proteins and cholesterol homeostasis
|
|
ES2831764T3
(es)
|
2016-04-29 |
2021-06-09 |
Orphazyme As |
Arimoclomol para el tratamiento de trastornos asociados a glucocerebrosidasa
|
|
US11666649B2
(en)
|
2016-10-11 |
2023-06-06 |
University Of Miami |
Vectors and vaccine cells for immunity against Zika virus
|
|
WO2018162450A1
(en)
|
2017-03-06 |
2018-09-13 |
Fundación Para La Investigación Médica Aplicada |
New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells
|
|
WO2018187260A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
EP3784688A2
(en)
|
2018-04-26 |
2021-03-03 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
EP4247792A1
(en)
|
2020-11-19 |
2023-09-27 |
Zevra Denmark A/S |
Processes for preparing arimoclomol citrate and intermediates thereof
|